Researchers at the University of Manchester have identified the genetic cause behind a rare condition considered one of the most common inherited causes of severe epilepsy in children. This breakthrough could significantly improve diagnosis and management for patients worldwide while providing long-awaited answers for affected families.
According to Medical Xpress, the condition has been named “RNU2-2–related recessive neurodevelopmental disorder.” It is characterized by severe, hard-to-control seizures and significant developmental delays, typically appearing within the first year of life, making early detection and intervention crucial.
Children affected by this disorder experience intense epileptic seizures caused by abnormal electrical activity in the brain, leading to symptoms such as muscle stiffness, convulsions, trembling, and sometimes loss of consciousness. These seizures are often resistant to conventional medications, highlighting the need for more advanced therapeutic approaches.
Beyond seizures, the condition has a profound impact on brain development, often preventing children from reaching key milestones such as walking and speaking. Most affected individuals also face significant learning difficulties that affect their overall quality of life.
The study, published in Nature Genetics, has so far identified dozens of confirmed cases worldwide, while researchers believe many more remain undiagnosed. Estimates suggest that a portion of the population may carry the defective gene without showing symptoms.
Researchers emphasize that this condition follows a recessive inheritance pattern, meaning a child must inherit the gene from both parents to be affected. This highlights the importance of genetic awareness and counseling, as carriers may be unaware of their status.
The team also noted that the gene responsible, RNU2-2, is unusually small and does not encode a protein, which makes it distinct from most genes and more challenging to study. Despite this, identifying it marks a major step toward understanding the biological mechanisms underlying epilepsy and neurodevelopmental disorders.
Ultimately, the researchers stress that such discoveries go beyond scientific progress—they provide clarity for families, improve diagnostic accuracy, and pave the way for future targeted therapies that could transform the lives of patients living with rare genetic conditions.
For more news and updates, follow Egypt Connect
